Point72 Asset Management, L.P. 13D and 13G filings for VistaGen Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 08:56 am Sale |
2023-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
Point72 Asset Management, L.P. | 822,334 3.000% |
-743,495 (-47.48%) |
Filing |
| 2023-10-05 4:47 pm Purchase |
2023-10-04 | 13G | VistaGen Therapeutics, Inc. VTGN |
Point72 Asset Management, L.P. | 1,565,829 5.600% |
1,565,829 (New Position) |
Filing |